Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 59   

Articles published

GNOM 3.14
price chart
Agilent Technologies Introduces Next-Generation Sequencing Cancer Research ...
SANTA CLARA, California--Agilent Technologies Inc. today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated genes found in acute ...
Related articles »  
Dako Sponsors European Pathology Congress for Second Straight Year
In addition to Dako Omnis and ClearSeq AML, Agilent will be demonstrating all of its complete pathology and genomics solutions, including NGS, IHC, ISH, histostaining and connectivity. Attendees can visit a fluorescence microscopy room to see some of ...
Related articles »  
Dako Sponsors Largest Histology Congress for 34th Year in a Row
Agilent will also showcase its complete pathology and genomics solutions, including NGS, IHC, ISH, histostaining and connectivity.
Related articles »  
Young Investors - Why Increasing Risk Is A Bad Idea For Your Portfolio
Those years weren't a complete loss, as I did end up making a few picks that were good enough to break about even overall, but had I known then what I know now I would have approached things much differently.
Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q3 2014 Results ...
Good day, ladies and gentlemen, and welcome to the BioReference Laboratories Inc. Third Quarter 2014 Earnings Conference Call.
Update: Myriad Genetics' Patents Are Facing Trouble Again (MYGN)
Sherri Bale, the co-founder and managing director of GeneDx, said, "If we cannot share our data, talk about what we find, and come to conclusions on what things mean, the whole genomics area is going to fall flat on its face. We have to share the data.".
Related articles »  
MoBiTec, Germany, Offers Clickable Isoprenoids Manufactured by Echelon ...
The isoprenoid is added after the protein is otherwise complete. ... Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. ... cell transfection reagents ...
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS
The collaborations with AstraZeneca PLC (AZN - Analyst Report), Janssen Biotech, Inc., and Sanofi (SNY - Analyst Report) are expected to develop a complete next-generation sequencing (NGS)-based oncology test system which will be a transition from ...
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS - Analyst Blog  NASDAQ
Related articles »  
Next-Gen Sequencing Is A Numbers Game
Sequencing the human genome the first time cost $3 billion and took 13 years to complete. That was in 2003. Eleven years later ... with a price tag of $10 million. Consisting of 10 ultra-high-throughput sequencers, each capable of generating up to 1.8 ...
Related articles »  
Data Virtualization Powers Next Generation Sample Intelligence
August 8, 2014 | Contributed Commentary | With more than one billion samples stored in biobanks around the world, research advancements, genomics and biomarker development, and reduced research budgets are all driving the need for unified sample ...